Get startedLog in
    Picture of Sandoz AG logo

    SDZ — Sandoz AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Sandoz Confirms European Commission Approval Of Ondibta, Expects Launch By Early 2027

    Picture of Sandoz AG logoSandoz AG
    14/01/2026 11:02
    Jan 14 (Reuters) - SANDOZ GROUP AG SDZ.S:

SANDOZ CONFIRMS EUROPEAN COMMISSION APPROVAL OF ONDIBTA® (INSULIN GLARGINE), STRENGTHENING OVERALL BIOSIMILARS LEADERSHIP AND POSITION IN DIABETES

EXPECTED LAUNCH BY EARLY 2027

Source text: ID:nEQ9K2sfZa

Further company coverage: SDZ.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Sandoz AG

    See all news